AKCEA-APO(a)-L

Novartis elects to keep one heart drug, discard the other from option deal with Akcea, Ionis
Endpoints
Thu, 12/19/19 - 12:51 pm
Novartis
Akcea
Ionis
AKCEA-APO(a)-L
ACEKA-APOCIII-L